CompoAtlas

Metaboleze PM

Natural health product licensed in Canada

Licence holder
LA Weight Loss, LLC
NPN or DIN-HM
80041773
Status
Inactive licence
Licence date
18 April 2013
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Magnésium

Source : Citrate de magnésium

33.34 mg100,020 µg
Thiamine

Source : Chlorhydrate de thiamine

3.34 mg10,020 µg
Valeriana officinalis

Source : Racine

Extraction ratio : 5:1

Dry plant equivalent : 166.7 mg

Potency : 0.8 % Valerenic acid

33.34 mgNot calculated
Riboflavine

Source : Riboflavine

3.34 mg10,020 µg
L-théanine

Source : L-Théanine

33.34 mgNot calculated
Acide d-pantothénique

Source : D-Pantothénate de calcium

3.34 mgNot calculated

Non-medicinal ingredients

Gélatine, Silice, Stéarate de magnésium, farine de riz

PopulationAgeQuantity per servingFrequency
AdultesNot specified3 Capsule1 day

Uses authorised in Canada

Helps to maintain good health. Help(s) relieve nervousness (calmative/sedative). Sleep aid / (to) help(s) to promote sleep. Helps in the development and maintenance of teeth and bones. Helps to maintain proper muscle function. Helps the body to metabolize carbohydrates, fats, and proteins.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80041773

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line